Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARγ

European Journal of Pharmacology

Volumn 552, Issue 1-3, 2006, Pages 112-122

  Zorad, Stefan ^b   Dou, Jing tao ^a   Benicky, Julius ^a   Hutanu, Daniel ^a   Tybitanclova, Katarina ^b   Zhou, Jin ^a   Saavedra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Adipocytes; Adipokines; Candesartan cilexetil; Renin angiotensin system

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN HEXETIL; CHOLESTEROL; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPOTROPHY; INSULIN BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; DRINKING; EATING; EPIDIDYMIS; GENE EXPRESSION; LEPTIN; LIPIDS; MALE; PPAR GAMMA; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLES; TIME FACTORS;

EID: 33751068479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.062     Document Type: Article

References (62)

1. 1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain. Ann. N.Y. Acad. Sci. 1018 (2004) 345-350
2. Arenas I.A., Xu Y., Lopez-Jaramillo P., and Davidge S.T. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am. J. Physiol., Cell Physiol. 286 (2004) C779-C784
3. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to stress. Endocrinology 142 (2001) 3880-3889
4. 1 receptor blockade prolongs lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin. Ann. N.Y. Acad. Sci. 1018 (2004) 131-136
5. Boustany C.M., Bharadwaj K., Daugherty A., Brown D.R., Randall D.C., and Cassis L.A. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am. J. Physiol., Regul. Integr. Comp. Physiol. 287 (2004) R943-R949
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. 1 receptor antagonism prevents stress-induced gastric injury. Am. J. Physiol.: Gasterointest. Liver Physiol. 285 (2003) G414-G423
8. Bunag R.D., and Butterfield J. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 4 (1982) 898-903
9. Cabassi A., Coghi P., Govoni P., Barouhiel E., Speroni E., Cavazzini S., Cantoni A.M., Scandroglio R., and Fiaccadori E. Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J. Clin. Endocrinol. Metab. 90 (2005) 2888-2897
10. Camp H.S., and Tafuri S.R. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 10811-10816
11. Campbell D.J., Kladis A., and Valentijn A.J. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J. Cardiovasc. Pharmacol. 26 (1995) 233-240
12. Cassis L.A., English V.L., Bharadwaj K., and Boustany C.M. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 145 (2004) 169-174
13. Crandall D.L., Herzlinger H.E., Saunders B.D., Armellino D.C., and Kral J.G. Distribution of angiotensin II receptors in rat and human adipocytes. J. Lipid Res. 35 (1994) 1378-1385
14. Darimont C., Vassaux G., Ailhaud G., and Negrel R. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin. Endocrinology 135 (1994) 2030-2036
15. Darimont C., Vassaux G., Gaillard D., Ailhaud G., and Negrel R. In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Int. J. Obes. Relat. Metab. Disord. 18 (1994) 783-788
16. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., Ailhaud G., Teboul M., Massiera F., and Sharma A.M. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int. J. Biochem. Cell Biol. 35 (2003) 807-825
17. Fasshauer M., Paschke R., and Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 86 (2004) 779-784
18. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
19. Friedman J.F., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
20. Goossens G.H., Blaak E.E., and van Baak M.A. Possible involvement of the adipose renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes. Rev. 4 (2003) 43-55
21. Gorzelniak K., Janke J., Engeli S., and Sharma A.M. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm. Metab. Res. 33 (2001) 625-627
22. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
23. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab. 30 (2004) 13-19
24. Gustafson B., Jack M.M., Cushman S.W., and Smith U. Adiponectin gene activation by thiazolidinediones requires PPARγ2, but not C/EBPα-evidence for differential regulation of the aP2 and adiponectin genes. Biochem. Biophys. Res. Commun. 308 (2003) 933-939
25. Hainault I., Nebout G., Turban S., Ardouin B., Ferre P., and Quignard-Boulange A. Adipose tissue-specific increase in angiotensinogen expression and secretion in obese (fa/fa) Zucker rat. Am. J. Physiol., Endocrinol Metabol. Gastrointest. Physiol. 282 (2002) E59-E66
26. Hattori Y., Akimoto K., Gross S.S., Hattori S., and Kasai K. Angiotensin-II-induced oxidative stress elicits hypoadiponectinemia in rats. Diabetologia 48 (2005) 1066-1074
27. Hollenberg A.N., Susulic V.S., Madura J.P., Zhang B., Moller D.E., Tontonoz P., Sarraf P., Spiegelman B.M., and Lowell B.B. Functional antagonism between CCAAT/enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J. Biol. Chem. 272 (1997) 5283-5290
28. Hosaka Y., Tawata M., Kurihara A., Ohtaka M., Endo T., and Onaya T. The regulation of two distinct glucose transporter (GLUTl and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 131 (1992) 159-165
29. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
30. Hu E., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274 (1996) 2100-2103
31. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., and Border W. Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 69 (2006) 105-113
32. Inada Y., Wada T., Ojima M., Sanada T., Shibouta Y., Kanagawa R., Ishimura Y., Fujisawa Y., and Nishikawa K. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 19 (1997) 1079-1099
33. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
34. Jandeleit-Dahm K.A., Tikellis C., Reid C.M., Johnston C.I., and Cooper M.E. Why blockade of renin-angiotensin system reduces the incidence of new-onset diabetes. J. Hypertens. 23 (2005) 463-473
35. Janke J., Engeli S., Gorzelniak K., Luft F.C., and Sharma A.M. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51 (2002) 1699-1707
36. Kim S., Whelan J., Claycombe K., Reath D.B., and Moustaid-Moussa N. Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. J. Nutr. 132 (2002) 1135-1140
37. Lazar M.A. PPARγ, 10 years later. Biochimie 87 (2005) 9-13
38. Llorens-Cortes C., Greenberg B., Huang H., and Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24 (1994) 538-548
39. Maeda N., Takahashi M., Funahashi T., Kihara S., Hishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., and Matsuzawa Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094-2099
40. Massiera F., Bloch-Faure M., Ceiler D., Murakami K., Fukamizu A., Gasc J.M., Quignard-Boulange A., Negrel R., Ailhaud G., Seydoux J., Meneton P., and Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 15 (2001) 2727-2729
41. 1-receptor blockers in isolated vessels of different origin. Hypertension 33 (1999) 1406-1413
42. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
43. Nguyen G., Burckle C.A., and Sraer J.D. Renin/prorenin receptor biochemistry and functional significance. Curr. Hypertens. Rep. 6 (2004) 129-132
44. Okada K., Hirano T., Ran J., and Adachi M. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens. Res. 27 (2004) 293-299
45. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57 (1977) 313-370
46. Peraldi P., and Spiegelman B. TNF-α and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 182 (1998) 169-175
47. 1 receptor protein but lower angiotensin II-binding in adipose tissue of rats with monosodium glutamate-induced obesity. Horm. Metab. Res. 33 (2001) 708-712
48. 1 receptor antagonist Candesartan in young spontaneously hypertensive rats. J. Am. Soc. Nephrol. 10 (1999) S116-S119
49. Ran J., Hirano T., and Adachi M. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am. J. Physiol., Endocrinol Metabol. Gastrointest. Physiol. 287 (2004) 227-232
50. Ran J., Hirano T., and Adachi M. Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats. J. Hypertens. 23 (2005) 1525-1530
51. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa, NJ 365-386
52. Saint-Marc P., Kozak L.P., Ailhaud G., Darimont C., and Negrel R. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 142 (2001) 487-492
53. Schupp M., Janke J., Clasen R., Unger T., and Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109 (2004) 2054-2057
54. Shyu K.G., Chen J.J., Shih N.L., Chang H., Wang D.L., Lien W.P., and Liew C.C. Angiotensinogen gene expression is induced by cyclic mechanical stretch in cultured rat cardiomyocytes. Biochem. Biophys. Res. Commun. 211 (1995) 241-248
55. Skurk T., van Harmelen V., and Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kB. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1199-1203
56. Torti F.M., Torti S.V., Larrick J.W., and Ringold G.M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J. Cell Biol. 108 (1989) 1105-1113
57. Tsuda T., Ueno Y., Aoki H., Koda T., Horio F., Takahashi N., Kawada T., and Osawa T. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 316 (2004) 149-157
58. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., and Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabeteologia 43 (2000) 1498-1506
59. Xing H., Northrop J.P., Grove J.R., Kilpatrick K.E., Su J.L., and Ringold G.M. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPAR gamma without effects on Prof-1 expression. Endocrinology 138 (1997) 2776-2783
60. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K., Miki H., Tsuchida A., Akanuma Y., Nagai R., Kimura S., and Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 44 (2001) 41245-41254
61. 1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J. Cereb. Blood Flow Metab. 25 (2005) 878-886
62. Zorad S., Macho L., Jezova D., and Fickova M. Partial characterization of insulin resistance in adipose tissue of monosodium glutamate-induced obese rats. Ann. N.Y. Acad. Sci. 827 (1997) 541-545